Oppenheimer Asset Management Inc. Acquires New Shares in HCA Healthcare, Inc. $HCA

Oppenheimer Asset Management Inc. acquired a new position in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 3,669 shares of the company’s stock, valued at approximately $1,431,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Norges Bank purchased a new stake in HCA Healthcare in the fourth quarter worth approximately $1,262,513,000. Life Cycle Investment Partners Ltd bought a new stake in shares of HCA Healthcare in the fourth quarter worth $374,037,000. Viking Global Investors LP lifted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in shares of HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of HCA Healthcare by 5,941.1% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 381,433 shares of the company’s stock worth $180,509,000 after purchasing an additional 375,119 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on HCA shares. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research note on Monday, July 27th. Stephens lowered their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. TD Cowen decreased their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Finally, Barclays cut their price objective on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $465.59.

View Our Latest Stock Analysis on HCA

HCA Healthcare Trading Down 0.0%

NYSE:HCA opened at $404.61 on Monday. The company has a market capitalization of $87.60 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10. The business’s 50-day moving average is $393.41 and its 200 day moving average is $446.61. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the firm earned $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.